HRA001330
Title:
Genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma
Release date:
2022-01-04
Description:
In this study, we systematically elaborated the overview usage of promoters in HCC. Different from previous studies concerned with gene expression, our study focused on pre-transcriptional regulation suggest that promoter activity was more effective and conducive for tumorigenesis exploration. Then the correlation between APs activity and methylation status indicated that APs activity could be regulated by the aberrant methylation status.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
hepatocellular carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Ximiao He
Contact person:
He Ximiao
Email:
XimiaoHe@hust.edu.cn
Description:
PI of Center for Genomics and Proteomics Research
Individuals & samples
Submitter:   He Ximiao / XimiaoHe@hust.edu.cn
Organization:   Tongji Medical College,Huazhong University of Science & Technology
Submission date:   2021-09-18
Requests:   1